Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target

被引:1
|
作者
Dattani, Abhishek [1 ]
Singh, Anvesha
Mccann, Gerry P.
Gulsin, Gaurav S.
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, England
关键词
diabetes; calcium handling; manganese-enhanced MRI; GLYCATION END-PRODUCTS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; CONGESTIVE-HEART-FAILURE; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; CARDIAC STRUCTURE; GENE-EXPRESSION; MANGANESE IONS; YOUNG-ADULTS; CARDIOMYOPATHY;
D O I
10.3390/jcdd11010012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2D) is a multisystem disease with rapidly increasing global prevalence. Heart failure has emerged as a major complication of T2D. Dysregulated myocardial calcium handling is evident in the failing heart and this may be a key driver of cardiomyopathy in T2D, but until recently this has only been demonstrated in animal models. In this review, we describe the physiological concepts behind calcium handling within the cardiomyocyte and the application of novel imaging techniques for the quantification of myocardial calcium uptake. We take an in-depth look at the evidence for the impairment of calcium handling in T2D using pre-clinical models as well as in vivo studies, following which we discuss potential novel therapeutic approaches targeting dysregulated myocardial calcium handling in T2D.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] A novel potential therapeutic target in metabolic disease: role of Ghrelin/GHSR/LEAP2 in type 2 diabetes and obesity
    Yue, L.
    Cheng, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S295 - S295
  • [42] Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention
    Hermida, Ramon C.
    Ayala, Diana E.
    Mojon, Artemio
    Fernandez, Jose R.
    DIABETOLOGIA, 2016, 59 (02) : 392 - 394
  • [43] Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
    Burant, Charles F.
    DIABETES CARE, 2013, 36 : S175 - S179
  • [44] SIRT1: a promising therapeutic target in type 2 diabetes mellitus
    Mihanfar, Ainaz
    Akbarzadeh, Maryam
    Darband, Saber Ghazizadeh
    Sadighparvar, Shirin
    Majidinia, Maryam
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2024, 130 (01) : 13 - 28
  • [45] Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention
    Ramón C. Hermida
    Diana E. Ayala
    Artemio Mojón
    José R. Fernández
    Diabetologia, 2016, 59 : 392 - 394
  • [46] Metabolic control of myofibers: promising therapeutic target for obesity and type 2 diabetes
    Duan, Yehui
    Li, Fengna
    Tan, Bie
    Yao, Kang
    Yin, Yulong
    OBESITY REVIEWS, 2017, 18 (06) : 647 - 659
  • [47] Oscillating blood pressure therapeutic target in type 2 diabetes patients with hypertension
    Tankeu, Aurel T.
    Noubiap, Jean Jacques N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (21)
  • [48] TYPE 2 DIABETES-ASSOCIATED ATHEROTHROMBOSIS: INSIGHTS INTO PATHOGENESIS AND THERAPEUTIC TARGET
    Ahmed, K.
    Muniandy, S.
    Ismail, I. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 203 - 203
  • [49] Plin5: A potential therapeutic target for type 2 diabetes mellitus
    Wei, Mengjuan
    Wang, Yan
    Zhang, Yufei
    Qiao, Yun
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [50] Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity
    Sasaoka, Toshiyasu
    Wada, Tsutomu
    Tsuneki, Hiroshi
    PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 799 - 809